Fibrogen Inc CS (FGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FGEN | ZTS | TAK | NBIX | UTHR |
| Company | Fibrogen Inc CS | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | Neurocrine Bioscienc | United Therapeutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 1.0500 | 159.64 | 13.14 | 138.07 | 236.28 |
| High | 1.1300 | 162.13 | 13.23 | 140.47 | 237.76 |
| Low | 1.0300 | 159.09 | 13.14 | 137.64 | 234.95 |
| Last | 1.1400 | 160.05 | 13.18 | 138.90 | 235.42 |
| Change | +0.0500 | +0.35 | +0.01 | +0.01 | -2.84 |
| % Change | +4.59% | +0.22% | +0.08% | +0.01% | -1.19% |
| Volume | 289,302 | 812,035 | 175,600 | 110,633 | 45,800 |
| 20-Day Average Volume | 1,765,373 | 4,341,297 | 1,671,050 | 709,156 | 451,306 |
| Previous Close | 1.0900 | 159.70 | 13.17 | 138.89 | 238.26 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.2752 | 156.79 | 13.34 | 136.41 | 235.34 |
| 20-Day Raw Stochastic | 12.72% | 65.53% | 28.57% | 61.20% | 59.23% |
| 20-Day Relative Strength | 36.46% | 46.47% | 39.04% | 54.07% | 51.57% |
| Weighted Alpha | -81.66 | -15.88 | -21.34 | +43.07 | +9.54 |
| Today's Opinion | 24% Sell | 72% Sell | 100% Sell | 80% Buy | 80% Buy |
| Previous Opinion | 24% Sell | 72% Sell | 100% Sell | 80% Buy | 80% Buy |
| Last Month's Opinion | 88% Buy | 56% Sell | 72% Sell | 100% Buy | 16% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.93% since 04/23/24 | +7.59% since 04/23/24 | -1.16% since 04/23/24 | -0.61% since 04/23/24 | +0.57% since 04/23/24 |
| Low | 0.9011 on 04/25/24 | 148.75 on 04/24/24 | 13.01 on 04/26/24 | 135.17 on 04/26/24 | 233.27 on 04/24/24 |
| High | 1.1700 on 04/29/24 | 165.04 on 04/29/24 | 13.33 on 04/24/24 | 144.70 on 04/24/24 | 241.00 on 04/24/24 |
| 1-Month | |||||
| %Chg | -54.89% since 03/28/24 | -4.90% since 03/28/24 | -4.79% since 03/28/24 | +0.95% since 03/28/24 | +2.65% since 03/28/24 |
| Low | 0.9011 on 04/25/24 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 130.13 on 04/19/24 | 221.53 on 04/01/24 |
| High | 2.3975 on 04/01/24 | 169.49 on 04/01/24 | 13.78 on 04/01/24 | 145.00 on 04/23/24 | 241.37 on 04/11/24 |
| 3-Month | |||||
| %Chg | -38.37% since 01/30/24 | -15.94% since 01/30/24 | -9.04% since 01/30/24 | -1.99% since 01/30/24 | +9.67% since 01/30/24 |
| Low | 0.9011 on 04/25/24 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 128.00 on 02/07/24 | 208.62 on 02/08/24 |
| High | 2.9300 on 02/12/24 | 200.53 on 02/29/24 | 14.88 on 02/27/24 | 148.37 on 03/21/24 | 250.89 on 03/26/24 |
| 6-Month | |||||
| %Chg | +111.28% since 10/30/23 | +2.49% since 10/30/23 | -1.01% since 10/30/23 | +29.96% since 10/30/23 | +6.88% since 10/30/23 |
| Low | 0.3333 on 11/10/23 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 103.63 on 11/10/23 | 208.62 on 02/08/24 |
| High | 2.9300 on 02/12/24 | 201.92 on 12/14/23 | 15.07 on 01/12/24 | 148.37 on 03/21/24 | 258.31 on 12/14/23 |
| Key Statistics | |||||
| Market Capitalization, $K | 108,427 | 73,040,232 | 41,680,904 | 13,820,528 | 11,212,275 |
| Shares Outstanding, K | 99,474 | 457,359 | 3,164,837 | 99,507 | 47,059 |
| Annual Sales | 147,750,000 | 8,544,000,000 | 29,803,340,000 | 1,887,100,000 | 2,327,500,000 |
| Annual Net Income | -284,230,000 | 2,344,000,000 | 2,345,930,000 | 249,700,000 | 984,800,000 |
| Last Quarter Sales | 27,140,000 | 2,213,000,000 | 7,556,070,000 | 515,200,000 | 614,700,000 |
| Last Quarter Net Income | -56,230,000 | 525,000,000 | 718,900,000 | 147,700,000 | 217,100,000 |
| 60-Month Beta | 0.70 | 0.85 | 0.53 | 0.25 | 0.52 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.57 on 02/26/24 | 1.24 on 02/13/24 | 0.51 on 02/01/24 | 1.44 on 02/07/24 | 4.36 on 02/21/24 |
| Latest Earnings Date | 05/13/24 | 05/02/24 | 05/09/24 | 05/01/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.432 on 04/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 04/18/24 | 09/28/23 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 29.78 | 6.68 | 56.19 | 11.79 |